C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/91 (2006.01) A61K 31/505 (2006.01) A61P 35/00 (2006.01) C07D 401/04 (2006.01) C07D 401/12 (2006.01) C07D 403/04 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2568756
The invention relates to chemical compounds of the formula (I): or pharmaceutically acceptable salts thereof, which possess B Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.
La présente invention a trait à des composés chimiques de formule (I), ou à leurs sels pharmaceutiquement acceptables, présentant une activité inhibitrice de B Raf et sont donc utiles pour leur activité anticancéreuse et donc dans des procédés de traitement de l'organisme humain ou animal. L'invention a également trait à des procédés pour la fabrication desdits composés chimiques, à des compositions pharmaceutiques les contenant et à leur utilisation dans la fabrication de médicaments utilisés dans la production d'un effet anticancéreux chez un animal à sang chaud tel que l'homme.
Aquila Brian
Dakin Les
Ezhuthachan Jayachandran
Lee John
Lyne Paul
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Substituted quinazolones as anti-cancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinazolones as anti-cancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinazolones as anti-cancer agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2060071